NASDAQ:BLUE
bluebird bio, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.bluebirdbio.comipo date
Jun 19, 2013
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene a...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus